Efficient delivery of miR-122 to regulate cholesterol metabolism using a non-covalent peptide-based strategy

Molecular Medicine Reports

Volumn 8, Issue 5, 2013, Pages 1472-1478

  Wang, Lilin ^a,b   Tang, Wei ^c   Yan, Shirong ^c   Zhou, Long ^d   Shen, Tao ^b   Huang, Xiuqing ^b   Dou, Lin ^b   Wang, Mo ^b   Yu, Songlin ^b   Li, Jian ^a,b  

^a WUHAN UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c HUBEI UNIVERSITY OF MEDICINE   (China)

^d Department of Medicine   (China)

Author keywords

Cholesterol metabolism; miRNA 122; MPG; MPG NLS; Non covalent peptide based strategy

Indexed keywords

CELL PENETRATING PEPTIDE; CELL PENETRATING PEPTIDE MPG; CHOLESTEROL; MICRORNA 122; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CAENORHABDITIS ELEGANS; CELL VIABILITY; CELLULAR DISTRIBUTION; CHOLESTEROL METABOLISM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; COVALENT BOND; GENE EXPRESSION; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER CELL; MALE; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; VECTOR CONTROL;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BLOTTING, WESTERN; CAENORHABDITIS ELEGANS; CELL PROLIFERATION; CELLS, CULTURED; CHOLESTEROL; HEPATOCYTES; HIV ENVELOPE PROTEIN GP41; HUMANS; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; PEPTIDE FRAGMENTS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84885093812     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1691     Document Type: Article

References (36)

1. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
2. Lee Y, Ahn C, Han J, et al: The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419, 2003.
3. Yi R, Qin Y, Macara IG and Cullen BR: Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17: 3011-3016, 2003.
4. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
5. Yekta S, Shih IH and Bartel DP: MicroRNA-directed cleavage of HOXB8 mRNA. Science 304: 594-596, 2004.
6. Hildebrandt-Eriksen ES, Aarup V, Persson R, Hansen HF, Munk ME and Orum H: A locked nucleic acid oligonucleotide targeting microRNA 122 is well-tolerated in cynomolgus monkeys. Nucleic Acid Ther 22: 152-161, 2012.
7. Elmén J, Lindow M, Schutz S, et al: LNA-mediated microRNA silencing in non-human primates. Nature 452: 896-899, 2008.
8. Heitz F, Morris MC and Divita G: Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br J Pharmacol 157: 195-206, 2009.
9. Zatsepin TS, Turner JJ, Oretskaya TS and Gait MJ: Conjugates of oligonucleotides and analogues with cell penetrating peptides as gene silencing agents. Curr Pharm Des 11: 3639-3654, 2005.
10. El-Andaloussi S, Holm T and Langel U: Cell-penetrating peptides: mechanisms and applications. Curr Pharm Des 11: 3597-3611, 2005.
11. Joliot A and Prochiantz A: Transduction peptides: from technology to physiology. Nat Cell Biol 6: 189-196, 2004.
12. Torchilin VP: Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliv Rev 60: 548-558, 2008.
13. Deshayes S, Morris M, Heitz F and Divita G: Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv Drug Deliv Rev 60: 537-547, 2008.
14. Deshayes S, Morris MC, Divita G and Heitz F: Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol Life Sci 62: 1839-1849, 2005.
15. Snyder EL and Dowdy SF: Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo. Expert Opin Drug Deliv 2: 43-51, 2005.
16. Eguchi A and Dowdy SF: siRNA delivery using peptide transduction domains. Trends Pharmacol Sci 30: 341-345, 2009.
17. Simeoni F, Morris MC, Heitz F and Divita G: Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res 31: 2717-2724, 2003.
18. Yoo JW, Hong SW, Kim S and Lee DK: Inflammatory cytokine induction by siRNAs is cell type-and transfection reagent-specific. Biochem Biophys Res Commun 347: 1053-1058, 2006.
19. Crombez L, Charnet A, Morris MC, Aldrian-Herrada G, Heitz F and Divita G: A non-covalent peptide-based strategy for siRNA delivery. Biochem Soc Trans 35: 44-46, 2007.
20. Lundberg P, El-Andaloussi S, Sutlu T, Johansson H and Langel U: Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J 21: 2664-2671, 2007.
21. Simeoni F, Morris MC, Heitz F and Divita G: Peptide-based strategy for siRNA delivery into mammalian cells. Methods Mol Biol 309: 251-260, 2005.
22. Morris MC, Chaloin L, Méry J, Heitz F and Divita G: A novel potent strategy for gene delivery using a single peptide vector as a carrier. Nucleic Acids Res 27: 3510-3517, 1999.
23. Morris KV, Chan SW, Jacobsen SE and Looney DJ: Small interfering RNA-induced transcriptional gene silencing in human cells. Science 305: 1289-1292, 2004.
24. Nguyen QN, Chavli RV, Marques JT, et al: Light controllable siRNAs regulate gene suppression and phenotypes in cells. Biochim Biophys Acta 1758: 394-403, 2006.
25. Esau C, Davis S, Murray SF, et al: miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98, 2006.
26. Liu GT, Carrazana EJ, Macklis JD and Mikati MA: Delayed oculogyric crises associated with striatocapsular infarction. J Clin Neuroophthalmol 11: 198-201, 1991.
27. Esau CC: Inhibition of microRNA with antisense oligonucleotides. Methods 44: 55-60, 2008.
28. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327: 198-201, 2010.
29. Méry J, Granier C, Juin M, and Brugidou J: Disulfide linkage to polyacrylic resin for automated Fmoc peptide synthesis. Immunochemical applications of peptide resins and mercaptoamide peptides. Int J Pept Protein Res 42: 44-52, 1993.
30. Salonpää P, Pelkonen O, Kojo A, Pasanen M, Negishi M and Raunio H: Cytochrome P4502A5 expression and inducibility by phenobarbital is modulated by cAMP in mouse primary hepatocytes. Biochem Biophys Res Commun 205: 631-637, 1994.
31. Dong J, Guo H, Yang R, et al: Serum LDL- and HDL-cholesterol determined by ultracentrifugation and HPLC. J Lipid Res 52: 383-388, 2011.
32. Krützfeldt J, Rajewsky N, Braich R, et al: Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689, 2005.
33. Crombez L, Morris MC, Heitz F and Divita G: A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery. Methods Mol Biol 764: 59-73, 2011.
34. Crombez L, Morris MC, Dufort S, et al: Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth. Nucleic Acids Res 37: 4559-4569, 2009.
35. Jones S and Howl J: Applications of cell-penetrating peptides as signal transduction modulators for the selective induction of apoptosis. Methods Mol Biol 683: 291-303, 2011.
36. Kimber MJ, McKinney S, McMaster S, Day TA, Fleming CC and Maule AG: flp gene disruption in a parasitic nematode reveals motor dysfunction and unusual neuronal sensitivity to RNA interference. FASEB J 21: 1233-1243, 2007.